Mif-1 (TFA) is a short tripeptide containing aromatic and hydrophobic residues arranged to favor compact structural motifs. The TFA form offers enhanced solubility and purification consistency. Researchers use it to explore residue-specific interactions, folding tendencies, and enzymatic behavior. Its small size supports high-sensitivity structural analysis.
CAT No: R2213
CAS No:35240-69-8
Synonyms/Alias:MIF-1 (TFA);MIF-1 TFA;35240-69-8;(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid;HY-107663A;MS-26730;CS-0136863;G17455;EN300-27126451;L-prolyl-L-leucyl-glycinamide,trifluoroacetatesalt;(2S)-N-(carbamoylmethyl)-4-methyl-2-{[(2S)-pyrrolidin-2-yl]formamido}pentanamide; trifluoroacetic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.